GlassScriptPhysician profile
Melissa R Richardson
NPI 1639199201
$317.53
in general payments reported to CMS, 2019-2025
8 companies · $21.31 in 2025
The $21.31 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35.89 · 2021: $31.30 · 2022: $11.74 · 2023: $74.24 · 2024: $143 · 2025: $21.31.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $238.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $112.50 | 2024 | Senza |
| Smith+Nephew, INC. | $66.55 | 2019-2024 | Grafix Pl, Pico, Renasys Go V2 Home |
| Organogenesis INC. | $31.30 | 2021 | |
| Medtronic, INC. | $30.01 | 2023-2024 | Intellis Adaptivestim, Invos |
| Abbvie INC. | $27.00 | 2023 | |
| Mindray Ds USA, INC. | $21.31 | 2025 | A7 Anesthesia System |
| Convatec INC. | $17.12 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.74 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Richardson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.